Table 1.
Baseline characteristics for COVID-19 patients: Intervention versus Control group.
| Characteristics | Intervention group (n = 36) | Control group (n = 36) | P-values |
|---|---|---|---|
| Male, n, % | 24 (66.7) | 25 (69.4) | 0.17 |
| Age, years, (M±SD) | 69.4 (8.0) | 68.9 (7.6) | 0.24 |
| BMI, kg/m2, (M±SD) | 23.1 (3.5) | 22.9 (3.9) | 0.12 |
| CT features of lung lesions, n | |||
| Multilobular lesion | 25 (69.4) | 23 (63.9) | 0.33 |
| Unilobar lesion | 11 (30.6) | 13 (36.1) | 0.27 |
| Pleural effusion | 4 (11.1) | 3 (8.3) | 0.18 |
| Comorbidity, n | |||
| Hypertension | 10 (27.8) | 8 (22.2) | 0.56 |
| T2DM | 9 (25.0) | 9 (25.0) | 0.67 |
| Osteoporosis | 8 (22.2) | 6 (16.7) | 0.41 |